| P50 | author | Michael Valenzuela | Q37782209 |
| P2093 | author name string | Thomas Duncan | |
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| | Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial. | Q55099772 |
| | Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind) | Q80142503 |
| | Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans | Q83388889 |
| | Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau. | Q39505649 |
| | The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells | Q39580297 |
| | Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer's disease | Q40365868 |
| | 2015 Alzheimer's disease facts and figures | Q40928952 |
| | Effects of engrafted neural stem cells in Alzheimer's disease rats | Q42446231 |
| | A phase 3 trial of semagacestat for treatment of Alzheimer's disease | Q42710153 |
| | High targeted migration of human mesenchymal stem cells grown in hypoxia is associated with enhanced activation of RhoA. | Q43099266 |
| | Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. | Q45925733 |
| | Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells | Q46491000 |
| | Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice | Q47882404 |
| | Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice | Q48165588 |
| | Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. | Q48448566 |
| | Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. | Q51053512 |
| | Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. | Q53315756 |
| | Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice | Q24534272 |
| | Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits | Q24598809 |
| | Induction of human neuronal cells by defined transcription factors | Q26269896 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 |
| | Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs | Q30659307 |
| | Human neural stem cells alleviate Alzheimer-like pathology in a mouse model. | Q30662068 |
| | The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons | Q33725851 |
| | Alzheimer's disease drug-development pipeline: few candidates, frequent failures | Q33892815 |
| | Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease | Q34157492 |
| | Migration and differentiation of nuclear fluorescence‐labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice | Q34271427 |
| | Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. | Q34487495 |
| | Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level | Q34979085 |
| | Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks | Q35132073 |
| | Angiomyeloproliferative lesions following autologous stem cell therapy | Q35153218 |
| | Alzheimer's disease as a disconnection syndrome? | Q35187202 |
| | Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease | Q35711351 |
| | Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. | Q35732928 |
| | Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke | Q35777502 |
| | The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor | Q35884401 |
| | Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases | Q36163658 |
| | Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss | Q36490240 |
| | Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease | Q37168959 |
| | Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. | Q37273874 |
| | Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model | Q37372219 |
| | Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells | Q37419124 |
| | Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer's disease | Q37424112 |
| | Teratomas from pluripotent stem cells: A clinical hurdle | Q37776212 |
| | Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. | Q37875244 |
| | Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model | Q38450926 |
| | Improvement of cognitive function and physical activity of aging mice by human neural stem cells over-expressing choline acetyltransferase | Q39144479 |
| | Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model. | Q39235167 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | dementia | Q83030 |
| | stem cell transplantation | Q65592366 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 111 | |
| P577 | publication date | 2017-05-12 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Alzheimer's disease, dementia, and stem cell therapy | |
| P478 | volume | 8 | |